INTECH Investment Management’s Rapport Therapeutics RAPP Stock Holding History
Bought
Maintained
Sold
Other funds holding RAPP
INTECH Investment Management's RAPP Position: Q3 2026 in Review
INTECH Investment Management sold out of Rapport Therapeutics (RAPP) in Q3 2026, closing a stake of 8,371 shares — an estimated $349K sold.
INTECH Investment Management first reported a position in RAPP in Q2 2025 and held it in 4 quarters. The position peaked at $349K in Q2 2026. 169 funds tracked by Wall St. Rank hold RAPP as of Q3 2026.
- INTECH Investment Management reported no remaining Rapport Therapeutics position as of Q3 2026 after selling out during the quarter.
- INTECH Investment Management sold 8,371 Rapport Therapeutics shares in Q3 2026, an estimated $349K.
- INTECH Investment Management first reported a position in Rapport Therapeutics in Q2 2025 and held it in 4 quarters.
- INTECH Investment Management's Rapport Therapeutics position peaked at $349K in Q2 2026.
- 169 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q3 2026.
Based on INTECH Investment Management's 13F filing for Q3 2026, filed 9 Nov 2026.